Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization

NCT06596291 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Neurogenic Detrusor Overactivity
Spinal Cord Injuries

Interventions

DRUG: EG110A

Sponsor

EG 427

Collaborators

[object Object]